Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Morand

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
The Journal of Antimicrobial Chemotherapy|February 18, 2022
Oral levofloxacin: population pharmacokinetics model and pharmacodynamics study in bone and joint infectionsEtienne Canouï, Solen Kerneis, Philippe Morand, et al.
Journal of Clinical Microbiology|November 21, 2008
Acute respiratory failure involving an R variant of Mycobacterium abscessusEmilie Catherinot, Anne-Laure Roux, Edouard Macheras, et al.
Plos One|December 1, 2016
TLR-2 Recognizes Propionibacterium acnes CAMP Factor 1 from Highly Inflammatory StrainsCoralie Lheure, Philippe Alain Grange, Guillaume Ollagnier, et al.
Infection|April 4, 2015
Pharmacokinetic variability of clindamycin and influence of rifampicin on clindamycin concentration in patients with bone and joint infectionsEmmanuel Curis, Vincent Pestre, Vincent Jullien, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 2, 2021
The minor pilin PilV provides a conserved adhesion site throughout the antigenically variable meningococcal type IV pilusJean-Philippe Barnier, Julie Meyer, Subramania Kolappan, et al.
Vaccine|January 13, 2009
Safety and immunogenicity of SC599, an oral live attenuated Shigella dysenteriae type-1 vaccine in healthy volunteers: results of a Phase 2, randomized, double-blind placebo-controlled trialOdile Launay, Christine Sadorge, Nathalie Jolly, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 22, 2022
Capnocytophaga zoonotic infections: a 10-year retrospective study (the French CANCAN study)Clémence Beauruelle, Chloé Plouzeau, Antoine Grillon, et al.
Pathogens (Basel, Switzerland)|March 26, 2022
Antimicrobial Resistance in Enterobacterales Recovered from Urinary Tract Infections in FranceEric Farfour, Laurent Dortet, Thomas Guillard, et al.
Microorganisms|June 24, 2022
Clinical Features and Outcome of Multidrug-Resistant Osteoarticular Tuberculosis: A 12-Year Case Series from FranceIsabelle Bonnet, Elie Haddad, Lorenzo Guglielmetti, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
The Journal of Antimicrobial Chemotherapy|February 18, 2022
Oral levofloxacin: population pharmacokinetics model and pharmacodynamics study in bone and joint infectionsEtienne Canouï, Solen Kerneis, Philippe Morand, et al.
Journal of Clinical Microbiology|November 21, 2008
Acute respiratory failure involving an R variant of Mycobacterium abscessusEmilie Catherinot, Anne-Laure Roux, Edouard Macheras, et al.
Plos One|December 1, 2016
TLR-2 Recognizes Propionibacterium acnes CAMP Factor 1 from Highly Inflammatory StrainsCoralie Lheure, Philippe Alain Grange, Guillaume Ollagnier, et al.
Infection|April 4, 2015
Pharmacokinetic variability of clindamycin and influence of rifampicin on clindamycin concentration in patients with bone and joint infectionsEmmanuel Curis, Vincent Pestre, Vincent Jullien, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 2, 2021
The minor pilin PilV provides a conserved adhesion site throughout the antigenically variable meningococcal type IV pilusJean-Philippe Barnier, Julie Meyer, Subramania Kolappan, et al.
Vaccine|January 13, 2009
Safety and immunogenicity of SC599, an oral live attenuated Shigella dysenteriae type-1 vaccine in healthy volunteers: results of a Phase 2, randomized, double-blind placebo-controlled trialOdile Launay, Christine Sadorge, Nathalie Jolly, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 22, 2022
Capnocytophaga zoonotic infections: a 10-year retrospective study (the French CANCAN study)Clémence Beauruelle, Chloé Plouzeau, Antoine Grillon, et al.
Pathogens (Basel, Switzerland)|March 26, 2022
Antimicrobial Resistance in Enterobacterales Recovered from Urinary Tract Infections in FranceEric Farfour, Laurent Dortet, Thomas Guillard, et al.
Microorganisms|June 24, 2022
Clinical Features and Outcome of Multidrug-Resistant Osteoarticular Tuberculosis: A 12-Year Case Series from FranceIsabelle Bonnet, Elie Haddad, Lorenzo Guglielmetti, et al.
Pageof 3